Name | Number of supported studies | Average coverage | |
---|---|---|---|
adipocyte | 9 studies | 48% ± 7% | |
enterocyte | 5 studies | 25% ± 9% |
Insufficient scRNA-seq data for expression of CIDEC at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 91% | 24643.96 | 419 / 459 | 61% | 15.00 | 687 / 1118 |
intestine | 37% | 1136.89 | 358 / 966 | 68% | 4.88 | 359 / 527 |
adipose | 100% | 33636.09 | 1202 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 5% | 59.96 | 17 / 328 | 82% | 14.24 | 146 / 178 |
stomach | 11% | 263.74 | 41 / 359 | 65% | 5.13 | 185 / 286 |
liver | 15% | 264.10 | 33 / 226 | 52% | 6.05 | 212 / 406 |
bladder | 29% | 513.14 | 6 / 21 | 26% | 1.75 | 132 / 504 |
skin | 29% | 544.98 | 522 / 1809 | 15% | 1.05 | 70 / 472 |
esophagus | 5% | 142.24 | 70 / 1445 | 33% | 3.94 | 61 / 183 |
adrenal gland | 14% | 198.05 | 35 / 258 | 7% | 1.22 | 15 / 230 |
ovary | 1% | 2.79 | 1 / 180 | 19% | 1.16 | 83 / 430 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.20 | 5 / 29 |
blood vessel | 17% | 938.66 | 224 / 1335 | 0% | 0 | 0 / 0 |
kidney | 1% | 134.63 | 1 / 89 | 15% | 1.72 | 137 / 901 |
lung | 0% | 0 | 0 / 578 | 15% | 1.53 | 177 / 1155 |
uterus | 5% | 31.75 | 9 / 170 | 10% | 0.86 | 46 / 459 |
thymus | 9% | 170.21 | 62 / 653 | 5% | 0.29 | 29 / 605 |
heart | 11% | 190.61 | 95 / 861 | 0% | 0 | 0 / 0 |
muscle | 10% | 92.53 | 81 / 803 | 0% | 0 | 0 / 0 |
prostate | 4% | 72.28 | 9 / 245 | 5% | 0.17 | 25 / 502 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
brain | 0% | 0 | 0 / 2642 | 1% | 0.01 | 7 / 705 |
peripheral blood | 1% | 6.04 | 5 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097194 | Biological process | execution phase of apoptosis |
GO_0006915 | Biological process | apoptotic process |
GO_0090209 | Biological process | negative regulation of triglyceride metabolic process |
GO_0120009 | Biological process | intermembrane lipid transfer |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0019915 | Biological process | lipid storage |
GO_0034389 | Biological process | lipid droplet organization |
GO_0050995 | Biological process | negative regulation of lipid catabolic process |
GO_0160077 | Biological process | lipid droplet fusion |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005811 | Cellular component | lipid droplet |
GO_0005634 | Cellular component | nucleus |
GO_0070300 | Molecular function | phosphatidic acid binding |
GO_0140693 | Molecular function | molecular condensate scaffold activity |
GO_0005515 | Molecular function | protein binding |
GO_0120013 | Molecular function | lipid transfer activity |
GO_0003674 | Molecular function | molecular_function |
Gene name | CIDEC |
Protein name | CIDEC protein Cell death inducing DFFA like effector c Lipid transferase CIDEC (Cell death activator CIDE-3) (Cell death-inducing DFFA-like effector protein C) (Fat-specific protein FSP27 homolog) |
Synonyms | FSP27 |
Description | FUNCTION: Lipid transferase specifically expressed in white adipose tissue, which promotes unilocular lipid droplet formation by mediating lipid droplet fusion . Lipid droplet fusion promotes their enlargement, restricting lipolysis and favoring lipid storage . Localizes on the lipid droplet surface, at focal contact sites between lipid droplets, and mediates atypical lipid droplet fusion by undergoing liquid-liquid phase separation (LLPS) and promoting directional net neutral lipid transfer from the smaller to larger lipid droplets . The transfer direction may be driven by the internal pressure difference between the contacting lipid droplet pair . Its role in neutral lipid transfer and lipid droplet enlargement is activated by the interaction with PLIN1 . May also act as a CEBPB coactivator in the white adipose tissue to control the expression of a subset of CEBPB downstream target genes, including SOCS1, SOCS3, TGFB1, TGFBR1, ID2 and XDH (By similarity). When overexpressed in preadipocytes, induces apoptosis or increases cell susceptibility to apoptosis induced by serum deprivation or TGFB treatment . . |
Accessions | ENST00000443115.1 ENST00000430427.6 [Q96AQ7-4] ENST00000336832.7 [Q96AQ7-1] ENST00000679265.1 [Q96AQ7-1] ENST00000383817.5 Q86XG0 ENST00000423850.5 [Q96AQ7-2] A0A0A0MRY9 ENST00000618572.4 [Q96AQ7-4] A0A0C4DG75 ENST00000675828.1 [Q96AQ7-1] Q96AQ7 ENST00000455015.6 [Q96AQ7-2] |